Tumor suppressor p53 stole the AKT in hypoxia

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Tumor hypoxia is linked to poor prognosis and is often worsened by p53 tumor suppressor loss.
• While functional p53 promotes apoptosis under hypoxia, the specific p53-dependent genes involved remain unclear.

Purpose of the Study:

• To identify p53-dependent genes induced by hypoxia that mediate apoptosis.
• To investigate the role of AKT signaling in p53-mediated apoptosis under hypoxic conditions.
• To evaluate the therapeutic potential of AKT inhibition in combination with radiation for hypoxic cancers.

Main Methods:

• Identification of a six-gene signature specifically induced by hypoxia in a p53-dependent manner.
• Analysis of gene signature downregulation in various cancer patient cohorts.
• Assessment of AKT inhibition's role in p53-mediated apoptosis.
• Evaluation of combined AKT inhibitor and ionizing radiation treatment in p53-deficient xenograft models.

Main Results:

• A six-gene signature mediating p53-dependent apoptosis under hypoxia was identified.
• Downregulation of this signature correlated with poor clinical outcomes across diverse cancers.
• AKT inhibition was found to mediate p53-dependent apoptosis induction under hypoxia.
• Combined AKT inhibition and ionizing radiation significantly reduced tumor size in a p53-deficient model.

Conclusions:

• The study elucidates key p53-dependent genes and pathways involved in hypoxic apoptosis.
• AKT inhibition shows therapeutic promise for inducing apoptosis in hypoxic, p53-deficient cancers.
• Targeting AKT signaling could be a viable strategy for improving cancer treatment outcomes.